CATALOGO DEI PRODOTTI DELLA RICERCA

Giollo, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.743
EU - Europa 1.407
AS - Asia 593
AF - Africa 12
OC - Oceania 11
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.736
CN - Cina 536
GB - Regno Unito 364
IT - Italia 202
IE - Irlanda 191
SE - Svezia 178
DE - Germania 164
FR - Francia 154
FI - Finlandia 46
RU - Federazione Russa 33
UA - Ucraina 23
VN - Vietnam 16
BE - Belgio 15
TR - Turchia 12
AU - Australia 10
CA - Canada 7
NL - Olanda 7
IR - Iran 6
EG - Egitto 5
PT - Portogallo 5
RO - Romania 5
ES - Italia 4
IN - India 4
JP - Giappone 4
TD - Ciad 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BR - Brasile 2
KR - Corea 2
LV - Lettonia 2
SI - Slovenia 2
ZA - Sudafrica 2
A1 - Anonimo 1
AR - Argentina 1
AT - Austria 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
Totale 3.777
Salva come PNG Salva come JPEG
Città #
Chandler 437
Southend 350
Dublin 184
Redmond 148
Ashburn 125
Jacksonville 108
Beijing 72
Lawrence 66
Princeton 66
Wilmington 63
Jinan 59
Ann Arbor 53
Houston 53
New York 51
Shenyang 47
Bologna 40
Nanjing 40
Woodbridge 38
Sindelfingen 37
Hebei 32
Helsinki 32
Verona 27
Haikou 23
Tianjin 23
Changsha 20
Ningbo 20
Hangzhou 19
Redwood City 19
Guangzhou 18
Washington 17
Zhengzhou 16
Taiyuan 15
Brussels 14
Seattle 14
San Francisco 13
Taizhou 13
Fairfield 12
Nanchang 12
Jiaxing 11
Norwalk 11
Falls Church 10
Detroit 9
Lanzhou 8
Dong Ket 7
Fuzhou 7
Rome 7
Esslingen am Neckar 6
Düsseldorf 5
Falkenstein 5
Milan 5
Shanghai 5
Brescia 4
Cagliari 4
Dongguan 4
Easton 4
London 4
Novokuznetsk 4
Sydney 4
Taichung 4
Tanta 4
Bangkok 3
Barcelona 3
Bari 3
Biandronno 3
Boston 3
Bratislava 3
Busto Garolfo 3
Cambridge 3
Chicago 3
Lappeenranta 3
Las Vegas 3
Menlo Park 3
Tarcento 3
Toronto 3
Venice 3
Xiangfen 3
Calais 2
Canberra 2
Cascina 2
Chapel Hill 2
Chiampo 2
Dearborn 2
Grassobbio 2
Groningen 2
Karda Mordo 2
Kemerovo 2
Leawood 2
Leeds 2
Legnaro 2
Leverkusen 2
Ljubljana 2
Luino 2
Manila 2
Mehlingen 2
Melbourne 2
Montréal 2
Muizenberg 2
Nave 2
Newark 2
Offlaga 2
Totale 2.624
Salva come PNG Salva come JPEG
Nome #
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 103
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 94
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 92
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 86
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 86
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 84
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 83
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 81
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 78
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 78
Rheumatoid arthritis, γδ T cells and bisphosphonates 76
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 73
The obesity paradox and osteoporosis 72
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 71
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease 69
Disease activity and left ventricular systolic function in rheumatoid arthritis 68
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 68
Effects of secukinumab on serum adipocytokines: preliminary data 67
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 66
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 66
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 65
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 64
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 64
Tuberculosis Infection Despite Isoniazid Prophylaxis in a Patient With Psoriatic Arthritis Treated With Etanercept 63
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 63
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 62
Association between environmental air pollution and rheumatoid arthritis flares 62
Investigational echocardiography for the detection of heart involvement in rheumatic musculoskeletal diseases 62
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 61
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 61
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 59
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 57
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 57
Correction to: The obesity paradox and osteoporosis 56
Biologics for Eosinophilic Granulomatosis with Polyangiitis: one size does not fit all 56
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 55
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 55
Prognostic Role of Subclinical Left Ventricular Systolic Dysfunction Evaluated by Speckle-Tracking Echocardiography in Rheumatoid Arthritis 54
Osteoporosis in Rheumatic Diseases 53
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 52
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 51
Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association? 51
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 50
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 49
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 49
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 47
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 47
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 47
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 46
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 45
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 44
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 42
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 42
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 42
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 42
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort 41
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 40
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 40
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 39
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 38
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 38
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 37
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 36
Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review 36
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 34
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 31
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 19
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 18
Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review 16
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 15
Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study 13
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 12
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 2
Totale 3.941
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.754
article - articoli 14.548
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 206
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 1 0 3
2019/2020299 35 4 6 30 28 42 36 6 35 20 13 44
2020/2021701 92 93 30 132 101 52 26 5 74 6 54 36
2021/2022640 69 175 4 40 29 18 14 29 55 17 33 157
2022/20231.255 80 133 105 220 118 281 30 61 154 15 44 14
2023/2024547 33 45 74 83 77 132 34 38 10 21 0 0
Totale 3.941